KORU Medical names Adam Kalbermatten as chief commercial officer
Go back to KORU Medical names Adam Kalbermatten as chief commercial officer| (NASDAQ: KRMD) | Delayed: 3.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.98 | 52 Week High | $ | |||
| Open | $4.01 | 52 Week Low | $ | |||
| Day High | $4.01 | P/E | N/A | |||
| Day Low | $3.90 | EPS | $ | |||
| Volume | 50,293 | |||||
